Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devin Sok

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Immunity|July 21, 2016
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging GlycansDevin Sok, Matthias Pauthner, Bryan Briney, et al.
Plos Pathogens|May 10, 2013
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycansJean-Philippe Julien, Devin Sok, Reza Khayat, et al.
Immunity|September 30, 2022
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized miceEleonora Melzi, Jordan R Willis, Krystal M Ma, et al.
Plos Pathogens|August 26, 2016
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Research Square|July 3, 2026
Vrc01-class Precursor Frequency in an African Population is Influenced by Ighv1-2 Allelic Composition and Not Malaria ExposureMichelle K Muthui, Caleb Kibet, Charity Muriuki, et al.
Plos Pathogens|September 15, 2016
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Microbiology Spectrum|March 22, 2023
Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization BreadthSuprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, et al.
Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Immunity|July 21, 2016
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging GlycansDevin Sok, Matthias Pauthner, Bryan Briney, et al.
Plos Pathogens|May 10, 2013
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycansJean-Philippe Julien, Devin Sok, Reza Khayat, et al.
Immunity|September 30, 2022
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized miceEleonora Melzi, Jordan R Willis, Krystal M Ma, et al.
Plos Pathogens|August 26, 2016
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Research Square|July 3, 2026
Vrc01-class Precursor Frequency in an African Population is Influenced by Ighv1-2 Allelic Composition and Not Malaria ExposureMichelle K Muthui, Caleb Kibet, Charity Muriuki, et al.
Plos Pathogens|September 15, 2016
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Microbiology Spectrum|March 22, 2023
Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization BreadthSuprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, et al.
Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Pageof 12